Transforming Cancer Therapeutics

Focus Areas:

• Next-generation immunotherapies and immunomodulatory drugs.
• Manipulation of the tumour microenvironment.
• Novel therapeutics tailored for paediatric cancers.
• Clinical decision support tools for treatment optimisation in children and young people.

Funding Type: Grant

Project Size: Total costs between £150,000 and £4 million, with a maximum grant request of £2 million.

Proposal Criteria:

• Projects should be innovation-driven, focusing on advanced immunotherapies or paediatric cancer treatments.
• Must adhere to the highest standards of animal welfare for proposals involving animal testing.
• Activities can range from laboratory experiments to phase 1 and 2 clinical trials, including prototyping, IP protection, and regulatory planning.

Portfolio Approach:

• Funding a diverse array of projects across immuno-oncology and paediatric oncology themes, technological maturities, and UK geographical locations.

Specific Themes:

• Focus on advanced immunotherapies, tumour microenvironment manipulation, paediatric cancer therapeutics, and clinical dosing optimisation tools.

Research Categories:

• Industrial research and experimental development projects.

Exclusions:

• Therapeutic approaches for adult cancers outside of immuno-oncology scope.
• Cancer diagnostics not aligned with specific immunotherapeutics or paediatric oncology approaches.
• Projects contingent on export performance or domestic input usage.

‍

Explore Grant Opportunities with Expert Guidance

Interested in learning more about this grant competition and how it can benefit your project?

Click here to book a consultation or send a message to discuss the details and explore how you can maximise your chances of success. If you're seeking support in crafting a compelling application, our experts are here to help. Let's collaborate to navigate the competition process and unlock new opportunities for your business.